Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -6.12
- Piotroski Score 3.00
- Grade Buy
- Symbol (TSBX)
- Company Turnstone Biologics Corp.
- Price $0.52
- Changes Percentage (-1.13%)
- Change -$0.01
- Day Low $0.51
- Day High $0.54
- Year High $5.75
Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/08/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.24
- Trailing P/E Ratio -0.86
- Forward P/E Ratio -0.86
- P/E Growth -0.86
- Net Income $-55,200,000
Income Statement
Quarterly
Annual
Latest News of TSBX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Turnstone Biologics Corp. (TSBX): This Penny Stock is a 'Strong Buy' According to Analysts
A list of the 10 best new penny stocks includes Turnstone Biologics Corp. (NASDAQ: TSBX), with a focus on biotechnology. Despite market volatility and recession fears, Turnstone is positioned well wit...
By Yahoo! Finance | 1 month ago -
Can Turnstone Biologics (NASDAQ:TSBX) Afford To Invest In Growth?
Investors are often drawn to unprofitable companies for potential high returns, like Amazon. Turnstone Biologics' cash burn rate, though reduced, raises concerns about future funding. Shareholders sho...
By Yahoo! Finance | 3 months ago
